Daniel A. Heller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Daniel A. Heller has a total of 720 co-authors. Here are the top co-authors by number of shared publications:
Mijin Kim
Memorial Sloan Kettering Cancer Center
34 shared publicationsJanki Shah
Memorial Sloan Kettering Cancer Center
26 shared publicationsRyan M. Williams
Department of Biomedical Engineering, The City College of New York (R.M.W.).
23 shared publicationsPrakrit Vaibhav Jena
Memorial Sloan Kettering Cancer Center
21 shared publications- Prakrit Vaibhav Jena
Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
21 shared publications Daniel Roxbury
University of Rhode Island
20 shared publications
Latest Publications
- 24 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6818)
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Fibrotic remodeling of tissues and tumors establishes immunosuppressive microenvironments that drive organ dysfunction and, in cancer, limit response to immunotherapy. Senescent-like cells are conserved drivers of fibrosis and therapeutic targets, yet their functional heterogeneity complicates therapeutic intervention. Here, we show that P-selectin is expressed by a subset of senescent-like cells in fibrotic tissues and tumors. Leveraging fucoidan-based nanoparticles that bind P-selectin, we developed senescence-modulating nanoparticles (SMNPs) to selectively target these disease-associated states. SMNPs exerted potent antifibrotic and immunomodulatory effects while improving the therapeutic index. Mechanistically, we identified a pathogenic, immunosuppressive macrophage population as a functional target in vivo. In fibrotic tumors, niche remodeling restored immune infiltration and sensitized tumors to immune checkpoint–based therapies. These findings establish SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.
- 24 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6818)
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Fibrotic remodeling of tissues and tumors establishes immunosuppressive microenvironments that drive organ dysfunction and, in cancer, limit response to immunotherapy. Senescent-like cells are conserved drivers of fibrosis and therapeutic targets, yet their functional heterogeneity complicates therapeutic intervention. Here, we show that P-selectin is expressed by a subset of senescent-like cells in fibrotic tissues and tumors. Leveraging fucoidan-based nanoparticles that bind P-selectin, we developed senescence-modulating nanoparticles (SMNPs) to selectively target these disease-associated states. SMNPs exerted potent antifibrotic and immunomodulatory effects while improving the therapeutic index. Mechanistically, we identified a pathogenic, immunosuppressive macrophage population as a functional target in vivo. In fibrotic tumors, niche remodeling restored immune infiltration and sensitized tumors to immune checkpoint–based therapies. These findings establish SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.
- 17 September 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 4 (11) , 1131-1144
Artificial intelligence and machine learning in nanoparticle drug delivery systems
- 17 September 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 4 (11) , 1131-1144
Artificial intelligence and machine learning in nanoparticle drug delivery systems
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 799
Machine Perception-Based Prediction of Pregnancy Loss
Over 15% of pregnancies result in miscarriage, yet no reliable indicators exist to inform clinicians or patients of the risk of pregnancy loss. Here, we established a liquid biopsy platform using machine learning to predict the risk of pregnancy loss, incorporating existing clinical biomarkers in combination with spectroscopic data from an optical nanosensor array. Biomarker and array data from sera of over 850 in vitro fertilization patients, collected two weeks after single euploid embryo transfer, were used to train and validate machine learning models to differentiate live birth from two categories of pregnancy loss: biochemical pregnancy or miscarriage. The combination of clinical biomarkers and nanosensor array responses led to the best prediction models, compared to either dataset alone, resulting in positive predictive values of 97.2% and 87.5% for biochemical pregnancy and miscarriage, respectively. These results suggest that a combination of known and unknown serum biomarkers from patients at the time of their first positive pregnancy test can provide a clinically meaningful aggregate prediction of risk of both early and later stage pregnancy loss.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 799
Machine Perception-Based Prediction of Pregnancy Loss
Over 15% of pregnancies result in miscarriage, yet no reliable indicators exist to inform clinicians or patients of the risk of pregnancy loss. Here, we established a liquid biopsy platform using machine learning to predict the risk of pregnancy loss, incorporating existing clinical biomarkers in combination with spectroscopic data from an optical nanosensor array. Biomarker and array data from sera of over 850 in vitro fertilization patients, collected two weeks after single euploid embryo transfer, were used to train and validate machine learning models to differentiate live birth from two categories of pregnancy loss: biochemical pregnancy or miscarriage. The combination of clinical biomarkers and nanosensor array responses led to the best prediction models, compared to either dataset alone, resulting in positive predictive values of 97.2% and 87.5% for biochemical pregnancy and miscarriage, respectively. These results suggest that a combination of known and unknown serum biomarkers from patients at the time of their first positive pregnancy test can provide a clinically meaningful aggregate prediction of risk of both early and later stage pregnancy loss.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (53) , 2540
Quantum Well Nanosensors for Diagnostic Applications
Quantum well nanosensors (QWNs) are composed of quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs). SWCNTs are highly sensitive to their local environment and are developed into electronic/electrochemical or optical sensors. QWDs introduce new chemical sensitivities on SWCNTs. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to detect and identify diseases.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (53) , 2540
Quantum Well Nanosensors for Diagnostic Applications
Quantum well nanosensors (QWNs) are composed of quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs). SWCNTs are highly sensitive to their local environment and are developed into electronic/electrochemical or optical sensors. QWDs introduce new chemical sensitivities on SWCNTs. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to detect and identify diseases.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 797
Non-Invasive Spectroscopic Detection of Brain Tumors Based on Chemically Modified Carbon Nanotube Array
The detection and identification of intracranial tumours is limited by the lack of accurate biomarkers and requires invasive biopsy procedures. We investigated a machine perception liquid biopsy approach to detect and identify intracranial tumours from peripheral blood and to discover biomarkers responsible for the predictions. Quantum well defect-modified single-walled carbon nanotubes stabilized with single-stranded DNA, interrogating 739 plasma samples from brain tumour patients, were used to train and validate machine-learning models to detect intracranial tumours with 98% accuracy and identify tumour type. The protein corona of the top model-contributing nanosensor was interrogated using quantitative proteomics, resulting in the identification of tumour ecosystem-secreted factors, both previously reported and newly discovered, originating from intracranial tumour cells, the tumour microenvironment and the innate immune system of patients with glioblastoma and meningioma. Newly discovered factors elicited linear nanosensor responses and were elevated in one or both tumour types, matching the original protein corona enrichment. This investigation reveals that a perception-based detection of disease in blood can identify biomarkers responsible for the signal and also amplify cancer detection signals by detecting factors beyond tumour cells, thereby recruiting the entire tumour ecosystem for cancer diagnosis.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 797
Non-Invasive Spectroscopic Detection of Brain Tumors Based on Chemically Modified Carbon Nanotube Array
The detection and identification of intracranial tumours is limited by the lack of accurate biomarkers and requires invasive biopsy procedures. We investigated a machine perception liquid biopsy approach to detect and identify intracranial tumours from peripheral blood and to discover biomarkers responsible for the predictions. Quantum well defect-modified single-walled carbon nanotubes stabilized with single-stranded DNA, interrogating 739 plasma samples from brain tumour patients, were used to train and validate machine-learning models to detect intracranial tumours with 98% accuracy and identify tumour type. The protein corona of the top model-contributing nanosensor was interrogated using quantitative proteomics, resulting in the identification of tumour ecosystem-secreted factors, both previously reported and newly discovered, originating from intracranial tumour cells, the tumour microenvironment and the innate immune system of patients with glioblastoma and meningioma. Newly discovered factors elicited linear nanosensor responses and were elevated in one or both tumour types, matching the original protein corona enrichment. This investigation reveals that a perception-based detection of disease in blood can identify biomarkers responsible for the signal and also amplify cancer detection signals by detecting factors beyond tumour cells, thereby recruiting the entire tumour ecosystem for cancer diagnosis.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 851
Boronic Acid Handle Chemistry for Highly Tunable Functionalization of Single-Walled Carbon Nanotubes
Single-walled carbon nanotubes (SWCNTs) possess unique optical and electronic properties that make them promising materials for applications in chemical sensing, imaging, and optoelectronics. Covalent functionalization of SWCNT introduces localized sp³ defects onto the sp2 carbon lattice, which can enhance these properties and enable the attachment of functional molecules such as catalysts or biomolecules. However, the standard approach of aryl diazonium induced defects suffers from key limitations, including harsh reaction conditions, poor control over the degree of functionalization that compromises reproducibility, and reliance on a relatively small set of commercially available diazonium salts. These constraints restrict chemical diversity and hinder systematic investigation of defect structure–property relationships.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 851
Boronic Acid Handle Chemistry for Highly Tunable Functionalization of Single-Walled Carbon Nanotubes
Single-walled carbon nanotubes (SWCNTs) possess unique optical and electronic properties that make them promising materials for applications in chemical sensing, imaging, and optoelectronics. Covalent functionalization of SWCNT introduces localized sp³ defects onto the sp2 carbon lattice, which can enhance these properties and enable the attachment of functional molecules such as catalysts or biomolecules. However, the standard approach of aryl diazonium induced defects suffers from key limitations, including harsh reaction conditions, poor control over the degree of functionalization that compromises reproducibility, and reliance on a relatively small set of commercially available diazonium salts. These constraints restrict chemical diversity and hinder systematic investigation of defect structure–property relationships.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 788
Machine Perception Liquid Biopsy via Quantum Well Nanosensors
A liquid biopsy is a blood test that provides similar kinds of molecular information as solid tissue biopsies, potentially enabling cancer diagnosis and monitoring. Most existing liquid biopsy technologies use molecular changes to circulating DNA, normally circulating tumor DNA (ctDNA). However, not all cancers produce sufficient ctDNA for diagnosis, especially in early-stage cancers. We are developing quantum well nanosensors (QWNs) composed of quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs) to enable new research and diagnostic methods for cancers and other indications. New synthetic methods for QWD-modified SWCNTs (color center nanotubes, CCNTs, or quantum-well defect nanotubes (QWNTs)) can enable new sensitivities of QWNs, improve yield and simplify processing. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to identify diseases. Also, by eluting and measuring the proteins captured and enriched on the QWNs (the protein corona) via mass spectrometry, QWNs enabled the discovery of new biomarkers responsible for their optical responses.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 788
Machine Perception Liquid Biopsy via Quantum Well Nanosensors
A liquid biopsy is a blood test that provides similar kinds of molecular information as solid tissue biopsies, potentially enabling cancer diagnosis and monitoring. Most existing liquid biopsy technologies use molecular changes to circulating DNA, normally circulating tumor DNA (ctDNA). However, not all cancers produce sufficient ctDNA for diagnosis, especially in early-stage cancers. We are developing quantum well nanosensors (QWNs) composed of quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs) to enable new research and diagnostic methods for cancers and other indications. New synthetic methods for QWD-modified SWCNTs (color center nanotubes, CCNTs, or quantum-well defect nanotubes (QWNTs)) can enable new sensitivities of QWNs, improve yield and simplify processing. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to identify diseases. Also, by eluting and measuring the proteins captured and enriched on the QWNs (the protein corona) via mass spectrometry, QWNs enabled the discovery of new biomarkers responsible for their optical responses.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 854
New Strategies for the Controlled Functionalization of Carbon Nanotubes Resulting in Quantum Well Defects
Covalent functionalization of single-walled carbon nanotubes (SWCNTs) enables controlled modulation of their optical and electronic properties. The deliberate introduction of localized sp3 defects creates emissive “quantum wells” that trap excitons and give rise to red-shifted near-infrared fluorescence. These defect-engineered nanotubes have attracted significant interest for applications in biosensing, bioimaging, and quantum optics. However, most established methods for generating such defects rely on a limited set of pre-activated reagents, restricting chemical diversity and constraining control over defect structure and electronic coupling.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 854
New Strategies for the Controlled Functionalization of Carbon Nanotubes Resulting in Quantum Well Defects
Covalent functionalization of single-walled carbon nanotubes (SWCNTs) enables controlled modulation of their optical and electronic properties. The deliberate introduction of localized sp3 defects creates emissive “quantum wells” that trap excitons and give rise to red-shifted near-infrared fluorescence. These defect-engineered nanotubes have attracted significant interest for applications in biosensing, bioimaging, and quantum optics. However, most established methods for generating such defects rely on a limited set of pre-activated reagents, restricting chemical diversity and constraining control over defect structure and electronic coupling.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 841
Enhancement of Arylated Carbon Nanotube Fluorescence
Covalently modified single walled carbon nanotubes, also known as color center nanotubes (CCNTs), can be used for a wide range of applications, including in sensing and disease diagnostics. These covalent modifications change the innate photoluminescence of SWCNTs generating new emission peaks (E11 - and E11 *-) in the fluorescence spectra that are redshifted from the native emission peak (E11). By modifying the surface of SWNCTs with different compounds, libraries of chemically diverse CCNTs can be generated. Many reactions have been developed to functionalize SWCNTs with alkyl and aryl defects, with arylation commonly achieved using diazonium salts. We have a found a novel synthesis method for arylated CCNTs that results in bright emission spectra with sharp emission peaks for the E11 - and E11 *-. These enhanced fluorescence peaks will enable the development of more robust and sensitive diagnostic systems.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 841
Enhancement of Arylated Carbon Nanotube Fluorescence
Covalently modified single walled carbon nanotubes, also known as color center nanotubes (CCNTs), can be used for a wide range of applications, including in sensing and disease diagnostics. These covalent modifications change the innate photoluminescence of SWCNTs generating new emission peaks (E11 - and E11 *-) in the fluorescence spectra that are redshifted from the native emission peak (E11). By modifying the surface of SWNCTs with different compounds, libraries of chemically diverse CCNTs can be generated. Many reactions have been developed to functionalize SWCNTs with alkyl and aryl defects, with arylation commonly achieved using diazonium salts. We have a found a novel synthesis method for arylated CCNTs that results in bright emission spectra with sharp emission peaks for the E11 - and E11 *-. These enhanced fluorescence peaks will enable the development of more robust and sensitive diagnostic systems.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 852
(Invited) Quantum Well Nanosensor Synthesis and Applications In Biomedicine
Quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs) enable expanded analyte sensitization and functionalization for biosensing applications. We are developing these materials into quantum well nanosensors (QWNs) to enable new research and diagnostic methods for cancers and other indications. New synthetic methods for QWD-modified SWCNTs (color center nanotubes, CCNTs, or quantum-well defect nanotubes (QWNTs)) can enable new sensitivities of QWNs, improve yield and simplify processing. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods and mass spectrometry. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to identify diseases. Also, by eluting and measuring the proteins captured and enriched on the QWNs (the protein corona) via mass spectrometry, QWNs enabled the discovery of new biomarkers responsible for their optical responses.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (10) , 852
(Invited) Quantum Well Nanosensor Synthesis and Applications In Biomedicine
Quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs) enable expanded analyte sensitization and functionalization for biosensing applications. We are developing these materials into quantum well nanosensors (QWNs) to enable new research and diagnostic methods for cancers and other indications. New synthetic methods for QWD-modified SWCNTs (color center nanotubes, CCNTs, or quantum-well defect nanotubes (QWNTs)) can enable new sensitivities of QWNs, improve yield and simplify processing. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods and mass spectrometry. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to identify diseases. Also, by eluting and measuring the proteins captured and enriched on the QWNs (the protein corona) via mass spectrometry, QWNs enabled the discovery of new biomarkers responsible for their optical responses.